Science Explorer Back to mapMap
Discussion
Company · Nijmegen · Netherlands

Xenikos (Netherlands)

Research works
2
▼ 89% vs 2018-21
Citations
8
4.3 per fractional work
Top-10% rate
11.8%
all institutions 10.0%
Open access
80%
world 40%
International
52%
world 18%

Not ranked overall: Xenikos (Netherlands) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Xenikos (Netherlands) work in?

In all years, 68% of research at Xenikos (Netherlands) is in Life Sciences, 32% in Health Sciences. Its largest fields are Immunology and Microbiology (53%), Medicine (32%), Agricultural and Biological Sciences (11%). It does 1.3× the world's share of Life Sciences.

Life Sciences68%Health Sciences32%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 2 domains and 4 fields, with their numbers
    1. Immunology and Microbiology152.6%
    2. Agricultural and Biological Sciences010.5%
    3. Biochemistry, Genetics and Molecular Biology05.3%
    1. Medicine131.6%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What are the most cited papers from Xenikos (Netherlands)?

The most cited paper from Xenikos (Netherlands) is "Phase I/II Trial of a Combination of Anti-CD3/CD7 Immunotoxins for Steroid-Refractory Acute Graft-versus-Host Disease" (Christoph Groth, Lenneke F. J. van Groningen, Tiago R. Matos et al., 2018), with 34 citations. Next come "Lessons learned from early closure of a clinical trial for steroid-refractory acute GVHD" (5) and "Does using a foreign language reduce mental imagery?" (4).

Most cited papers
#PaperReleasedCitations
1 Phase I/II Trial of a Combination of Anti-CD3/CD7 Immunotoxins for Steroid-Refractory Acute Graft-versus-Host Disease Christoph Groth, Lenneke F. J. van Groningen, Tiago R. Matos et al. · Transplantation and Cellular Therapy Open access 3 Nov 2018 34
2 Lessons learned from early closure of a clinical trial for steroid-refractory acute GVHD Gabrielle Meyers, Mehdi Hamadani, Michael J. Martens et al. · Bone Marrow Transplantation Open access 23 Nov 2021 5
3 Does using a foreign language reduce mental imagery? Guillermo Montero‐Melis, Petrus Isaksson, Jeroen van Paridon et al. PreprintOpen access 19 Sep 2019 4
4 Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: final report of BMT CTN 2002 Gabrielle Meyers et al. · Bone Marrow Transplantation Open access 25 Sep 2023 3
5 A Phase I/II Study on the Anti-CD3/CD7 Immunotoxin Combination (T-GuardTM) for the Treatment of Steroid-Refractory Acute Gvhd Christoph Groth, Lenneke F. J. van Groningen, Manita E. J. Bremmers et al. · Blood 7 Dec 2017 1
All 6 most cited papers, with filters and sorting

Which research topics does Xenikos (Netherlands) publish most on?

By volume in 2022-now: Coleoptera Taxonomy and Distribution, Coleoptera: Cerambycidae studies and Biological Control of Invasive Species.

  1. 1 Coleoptera Taxonomy and Distribution Ecology, Evolution, Behavior and Systematics 0 works
  2. 2 Coleoptera: Cerambycidae studies Ecology, Evolution, Behavior and Systematics 0 works
  3. 3 Biological Control of Invasive Species Insect Science 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available80.2%not open19.8%

World: 40% of research is openly available.

with international co-authors52.4%domestic only47.6%

World: 18% is written across borders.

How has Xenikos (Netherlands)'s research output changed?

Output in 2022-2025 was 89% lower than in 2018-2021.

2020

Other research institutions in Nijmegen

All research institutions in Nijmegen

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Xenikos (Netherlands). Posts are plain text and can be reported.